2022年利息费用占营业利润的34%,负担很重。
2022年有0.17亿的其他净收入,如果不考虑的话相对于2021年并没有增...查看全文
资本主义拉美行不通2017-05-10 19:23
$INC Research Holdings(INCR)$收购$inVentiv Health(VTIV)$的交易太棒了,几乎不用增加负债,哈哈哈哈!!昆泰你颤抖了吗?查看全文
$INC Research Holdings, Inc.(INCR)$ 内部交易: 2017-06-30,CEO,Macdonald Alistair ,期权,9467普通股, $16.06
$INC Research Holdings, Inc.(INCR)$ 内部交易: 2017-07-03,CAO, GC & Sec,Gaenzle Christopher L ,卖出,956普通股, $58.55
$INC Research Holdings, Inc.(INCR)$ 内部交易: 2017-06-30,CAO, GC & Sec,Gaenzle Christopher L ,卖出,5917普通股, $58.29
$INC Research Holdings, Inc.(INCR)$ 内部交易: 2017-06-30,CAO, GC & Sec,Gaenzle Christopher L ,期权,5917普通股, $16.06
$INC Research Holdings, Inc.(INCR)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2017-06-30 AccNo: 0001193125-17-220226 Size: 4 MB 网页链接
$INC Research Holdings(INCR)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-06-23 AccNo: 0001193125-17-211736 Size: 63 KB 网页链接
$INC Research Holdings(INCR)$ PREM14A - Preliminary proxy statements relating to merger or acquisition Filed: 2017-06-09 AccNo: 0001193125-17-200179 Size: 4 MB 网页链接
$INC Research Holdings(INCR)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-06-05 AccNo: 0001193125-17-194603 Size: 41 KB 网页链接
$INC Research Holdings(INCR)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-05-26 AccNo: 0001193125-17-185587 Size: 987 KB 网页链接
$INC Research Holdings(INCR)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-05-26 AccNo: 0001193125-17-185582 Size: 29 KB 网页链接